{"transactions":[{"id":696940,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-04T19:13:52.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":4696,"price":24.92,"value":117024.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":96295,"source":{"system":"sec-edgar","filing":"0001193125-26-332536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526332536/ownership.xml","form_type":"4"}},{"id":714561,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-06T19:37:09.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":4698,"price":33.13,"value":155644.74,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":100991,"source":{"system":"sec-edgar","filing":"0001193125-26-296128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526296128/ownership.xml","form_type":"4"}},{"id":756760,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-01T23:11:52.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":4653,"price":23.77,"value":110601.81,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":105689,"source":{"system":"sec-edgar","filing":"0001786335-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000178633526000002/ownership.xml","form_type":"4"}},{"id":793565,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T21:35:58.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":4683,"price":24.9,"value":116606.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":110342,"source":{"system":"sec-edgar","filing":"0001193125-26-204402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526204402/ownership.xml","form_type":"4"}},{"id":804331,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-20T21:09:33.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":59952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":59952,"derivative":{"exercise_price":24.52,"expiration_date":"2036-04-16","underlying":"Common Stock","underlying_shares":59952},"source":{"system":"sec-edgar","filing":"0001193125-26-164247","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526164247/ownership.xml","form_type":"4"}},{"id":804330,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-20T21:09:33.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":34674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":115025,"source":{"system":"sec-edgar","filing":"0001193125-26-164247","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526164247/ownership.xml","form_type":"4"}},{"id":819043,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T22:19:58.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":4683,"price":20.97,"value":98202.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":80351,"source":{"system":"sec-edgar","filing":"0001193125-26-140702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526140702/ownership.xml","form_type":"4"}},{"id":865572,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:50:25.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":1635,"price":22.4,"value":36624.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":85034,"source":{"system":"sec-edgar","filing":"0001193125-26-089107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089107/ownership.xml","form_type":"4"}},{"id":865571,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:50:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":3119,"price":22.54,"value":70302.26,"ownership":{"direct":true},"balance_after":86669,"source":{"system":"sec-edgar","filing":"0001193125-26-089107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089107/ownership.xml","form_type":"4"}},{"id":865570,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:50:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":5290,"price":22.8,"value":120612.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range"}],"balance_after":89788,"source":{"system":"sec-edgar","filing":"0001193125-26-089107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089107/ownership.xml","form_type":"4"}},{"id":865569,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:50:25.000Z","date":"2026-03-01","kind":"grant","planned":true,"acquired":true,"shares":6143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metric."}],"balance_after":95078,"source":{"system":"sec-edgar","filing":"0001193125-26-089107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089107/ownership.xml","form_type":"4"}},{"id":921248,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T17:00:41.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":3061,"price":23.56,"value":72117.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":88935,"source":{"system":"sec-edgar","filing":"0001193125-26-034832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526034832/ownership.xml","form_type":"4"}},{"id":950362,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:07:21.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":3150,"price":22.84,"value":71946.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":91996,"source":{"system":"sec-edgar","filing":"0001193125-26-002410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526002410/ownership.xml","form_type":"4"}},{"id":972422,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T17:10:22.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":3081,"price":36.38,"value":112086.78,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":95146,"source":{"system":"sec-edgar","filing":"0001193125-25-315460","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312525315460/ownership.xml","form_type":"4"}},{"id":1019036,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-14T16:15:06.000Z","date":"2025-10-13","kind":"sale","planned":false,"acquired":false,"shares":7942,"price":31.51,"value":250252.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":98227,"source":{"system":"sec-edgar","filing":"0001193125-25-238708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312525238708/ownership.xml","form_type":"4"}},{"id":1214632,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T16:53:00.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":1785,"price":40.4,"value":72114.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.73 to $41.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":106169,"source":{"system":"sec-edgar","filing":"0000950170-25-036056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025036056/ownership.xml","form_type":"4"}},{"id":1226894,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:56:50.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":28160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":28160,"derivative":{"exercise_price":42.92,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":28160},"source":{"system":"sec-edgar","filing":"0000950170-25-032750","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032750/ownership.xml","form_type":"4"}},{"id":1226893,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:56:50.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":15653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":107954,"source":{"system":"sec-edgar","filing":"0000950170-25-032750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032750/ownership.xml","form_type":"4"}},{"id":1387476,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-11T20:48:48.000Z","date":"2024-10-10","kind":"sale","planned":false,"acquired":false,"shares":7465,"price":52.76,"value":393853.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":92301,"source":{"system":"sec-edgar","filing":"0000950170-24-114378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024114378/ownership.xml","form_type":"4"}},{"id":1594539,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T01:23:34.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":34200,"derivative":{"exercise_price":53.69,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0000950170-24-026672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026672/ownership.xml","form_type":"4"}},{"id":1594538,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:23:34.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":19400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.  The amount of securities beneficially owned in column 5 reflects the correction of a typographical error in the Form 4 filed by the Reporting Person on October 10, 2023 (the \"October 2023 Form 4\").  The accurate number of securities beneficially owned by the Reporting Person in Column 5 of the October 2023 Form 4 is 80,366."}],"balance_after":99766,"source":{"system":"sec-edgar","filing":"0000950170-24-026672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026672/ownership.xml","form_type":"4"}},{"id":1762389,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-10T16:50:04.000Z","date":"2023-10-09","kind":"grant","planned":false,"acquired":true,"shares":140469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares initially subject to the option shall continue to vest on each month such that the option will fully vest on the fourth anniversary of the grant date."}],"balance_after":140469,"derivative":{"exercise_price":35.68,"expiration_date":"2033-10-09","underlying":"Common Stock","underlying_shares":140469},"source":{"system":"sec-edgar","filing":"0001209191-23-052466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123052466/doc4.xml","form_type":"4"}},{"id":1762388,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-10T16:50:04.000Z","date":"2023-10-09","kind":"grant","planned":false,"acquired":true,"shares":80366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's Employment Inducement Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":80336,"source":{"system":"sec-edgar","filing":"0001209191-23-052466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123052466/doc4.xml","form_type":"4"}},{"id":1993358,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-25T01:36:25.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":2248,"price":25.973,"value":58387.304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":230712,"source":{"system":"sec-edgar","filing":"0001209191-23-013007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123013007/doc4.xml","form_type":"4"}},{"id":2003607,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-22T00:22:45.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":2424,"price":25.288,"value":61298.112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":232960,"source":{"system":"sec-edgar","filing":"0001209191-23-011382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011382/doc4.xml","form_type":"4"}},{"id":2374897,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T02:29:59.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":29.48,"expiration_date":"2032-02-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-012951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012951/doc4.xml","form_type":"4"}},{"id":2374896,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-02-25T02:29:59.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":235384,"source":{"system":"sec-edgar","filing":"0001209191-22-012951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012951/doc4.xml","form_type":"4"}},{"id":2382304,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-02-22T22:00:19.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":2393,"price":31.9309,"value":76410.6437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":200384,"source":{"system":"sec-edgar","filing":"0001209191-22-011735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011735/doc4.xml","form_type":"4"}},{"id":2850444,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T22:01:27.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":67.38,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-011920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011920/doc4.xml","form_type":"4"}},{"id":2850443,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-02-18T22:01:27.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":202777,"source":{"system":"sec-edgar","filing":"0001209191-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011920/doc4.xml","form_type":"4"}},{"id":3082815,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-15T20:50:43.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":30000,"price":50.0577,"value":1501731.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":177777,"source":{"system":"sec-edgar","filing":"0001209191-20-042489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120042489/doc4.xml","form_type":"4"}},{"id":3092126,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-02T22:42:10.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":10000,"price":40,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":207777,"source":{"system":"sec-edgar","filing":"0001209191-20-040660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/doc4.xml","form_type":"4"}},{"id":3092125,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-02T22:42:10.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":400,"price":39.33,"value":15732.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":217777,"source":{"system":"sec-edgar","filing":"0001209191-20-040660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/doc4.xml","form_type":"4"}},{"id":3092124,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-02T22:42:10.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":500,"price":38.784,"value":19392.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price and includes 200 shares sold at $38.19 and 300 shares sold at $39.18."}],"balance_after":218177,"source":{"system":"sec-edgar","filing":"0001209191-20-040660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/doc4.xml","form_type":"4"}},{"id":3092123,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-07-02T22:42:10.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":9100,"price":37.7225,"value":343274.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.16 to $38.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":218677,"source":{"system":"sec-edgar","filing":"0001209191-20-040660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/doc4.xml","form_type":"4"}},{"id":3098566,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-06-26T21:00:11.000Z","date":"2020-06-25","kind":"sale","acquired":false,"shares":30000,"price":50,"value":1500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":227777,"source":{"system":"sec-edgar","filing":"0001209191-20-039103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120039103/doc4.xml","form_type":"4"}},{"id":3102018,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-06-23T21:00:11.000Z","date":"2020-06-19","kind":"sale","acquired":false,"shares":10000,"price":40,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":257777,"source":{"system":"sec-edgar","filing":"0001209191-20-038511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120038511/doc4.xml","form_type":"4"}},{"id":3127213,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-06-03T01:14:48.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":6714,"price":35.3847,"value":237572.8758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":267777,"source":{"system":"sec-edgar","filing":"0001209191-20-033779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/doc4.xml","form_type":"4"}},{"id":3127212,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-06-03T01:14:48.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":3286,"price":34.5299,"value":113465.2514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":274491,"source":{"system":"sec-edgar","filing":"0001209191-20-033779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/doc4.xml","form_type":"4"}},{"id":3244004,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-28T00:56:03.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the stock option vest and become exercisable on February 25, 2021, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":21.73,"expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-013608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120013608/doc4.xml","form_type":"4"}},{"id":3394482,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":26579,"kind":"person","name":"Horn Howard","position":1,"cik":"0001786335","reported_name":"Horn Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-11T23:39:34.000Z","date":"2019-10-10","kind":"grant","acquired":true,"shares":111111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the stock option vest and become exercisable on October 10, 2020, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":111111,"derivative":{"exercise_price":20,"expiration_date":"2029-10-10","underlying":"Common Stock","underlying_shares":111111},"source":{"system":"sec-edgar","filing":"0001209191-19-053065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053065/doc4.xml","form_type":"4"}}]}